232 related articles for article (PubMed ID: 19919568)
21. Increased Frequency of Activated Switched Memory B Cells and Its Association With the Presence of Pulmonary Fibrosis in Diffuse Cutaneous Systemic Sclerosis Patients.
Simon D; Balogh P; Erdő-Bonyár S; Böröcz K; Minier T; Czirják L; Berki T
Front Immunol; 2021; 12():686483. PubMed ID: 34276673
[TBL] [Abstract][Full Text] [Related]
22. ST6Gal-I restrains CD22-dependent antigen receptor endocytosis and Shp-1 recruitment in normal and pathogenic immune signaling.
Grewal PK; Boton M; Ramirez K; Collins BE; Saito A; Green RS; Ohtsubo K; Chui D; Marth JD
Mol Cell Biol; 2006 Jul; 26(13):4970-81. PubMed ID: 16782884
[TBL] [Abstract][Full Text] [Related]
23. Altered B lymphocyte function induces systemic autoimmunity in systemic sclerosis.
Sato S; Fujimoto M; Hasegawa M; Takehara K; Tedder TF
Mol Immunol; 2004 Nov; 41(12):1123-33. PubMed ID: 15482848
[TBL] [Abstract][Full Text] [Related]
24. Autoantibodies to estrogen receptor α in systemic sclerosis (SSc) as pathogenetic determinants and markers of progression.
Giovannetti A; Maselli A; Colasanti T; Rosato E; Salsano F; Pisarri S; Mezzaroma I; Malorni W; Ortona E; Pierdominici M
PLoS One; 2013; 8(9):e74332. PubMed ID: 24058548
[TBL] [Abstract][Full Text] [Related]
25. Vascular receptor autoantibodies in pulmonary arterial hypertension associated with systemic sclerosis.
Becker MO; Kill A; Kutsche M; Guenther J; Rose A; Tabeling C; Witzenrath M; Kühl AA; Heidecke H; Ghofrani HA; Tiede H; Schermuly RT; Nickel N; Hoeper MM; Lukitsch I; Gollasch M; Kuebler WM; Bock S; Burmester GR; Dragun D; Riemekasten G
Am J Respir Crit Care Med; 2014 Oct; 190(7):808-17. PubMed ID: 25181620
[TBL] [Abstract][Full Text] [Related]
26. CD19 amplification of B lymphocyte Ca2+ responses: a role for Lyn sequestration in extinguishing negative regulation.
Fujimoto M; Poe JC; Hasegawa M; Tedder TF
J Biol Chem; 2001 Nov; 276(48):44820-7. PubMed ID: 11584010
[TBL] [Abstract][Full Text] [Related]
27. Circulating anticentromere CENP-A and CENP-B antibodies in patients with diffuse and limited systemic sclerosis, systemic lupus erythematosus, and rheumatoid arthritis.
Russo K; Hoch S; Dima C; Varga J; Teodorescu M
J Rheumatol; 2000 Jan; 27(1):142-8. PubMed ID: 10648030
[TBL] [Abstract][Full Text] [Related]
28. CD22 regulates adaptive and innate immune responses of B cells.
Kawasaki N; Rademacher C; Paulson JC
J Innate Immun; 2011; 3(4):411-9. PubMed ID: 21178327
[TBL] [Abstract][Full Text] [Related]
29. Clinical and serological evaluation of a novel CENP-A peptide based ELISA.
Mahler M; Maes L; Blockmans D; Westhovens R; Bossuyt X; Riemekasten G; Schneider S; Hiepe F; Swart A; Gürtler I; Egerer K; Fooke M; Fritzler MJ
Arthritis Res Ther; 2010; 12(3):R99. PubMed ID: 20487535
[TBL] [Abstract][Full Text] [Related]
30. B lymphocytes: shedding new light on the pathogenesis of systemic sclerosis.
Hasegawa M
J Dermatol; 2010 Jan; 37(1):3-10. PubMed ID: 20175836
[TBL] [Abstract][Full Text] [Related]
31. Dendritic cell-dependent inhibition of B cell proliferation requires CD22.
Santos L; Draves KE; Boton M; Grewal PK; Marth JD; Clark EA
J Immunol; 2008 Apr; 180(7):4561-9. PubMed ID: 18354178
[TBL] [Abstract][Full Text] [Related]
32. Lack of detection of agonist activity by antibodies to platelet-derived growth factor receptor alpha in a subset of normal and systemic sclerosis patient sera.
Loizos N; Lariccia L; Weiner J; Griffith H; Boin F; Hummers L; Wigley F; Kussie P
Arthritis Rheum; 2009 Apr; 60(4):1145-51. PubMed ID: 19333919
[TBL] [Abstract][Full Text] [Related]
33. Plasma cytokine profiles in systemic sclerosis: associations with autoantibody subsets and clinical manifestations.
Gourh P; Arnett FC; Assassi S; Tan FK; Huang M; Diekman L; Mayes MD; Reveille JD; Agarwal SK
Arthritis Res Ther; 2009; 11(5):R147. PubMed ID: 19799786
[TBL] [Abstract][Full Text] [Related]
34. Genetic Interaction between Lyn, Ets1, and Btk in the Control of Antibody Levels.
Mayeux J; Skaug B; Luo W; Russell LM; John S; Saelee P; Abbasi H; Li QZ; Garrett-Sinha LA; Satterthwaite AB
J Immunol; 2015 Sep; 195(5):1955-63. PubMed ID: 26209625
[TBL] [Abstract][Full Text] [Related]
35. CD22 associates with protein tyrosine phosphatase 1C, Syk, and phospholipase C-gamma(1) upon B cell activation.
Law CL; Sidorenko SP; Chandran KA; Zhao Z; Shen SH; Fischer EH; Clark EA
J Exp Med; 1996 Feb; 183(2):547-60. PubMed ID: 8627166
[TBL] [Abstract][Full Text] [Related]
36. Regulation of MHC class II signal transduction by the B cell coreceptors CD19 and CD22.
Bobbitt KR; Justement LB
J Immunol; 2000 Nov; 165(10):5588-96. PubMed ID: 11067914
[TBL] [Abstract][Full Text] [Related]
37. Epitope Specificity Determines Pathogenicity and Detectability of Anti-Platelet-Derived Growth Factor Receptor α Autoantibodies in Systemic Sclerosis.
Moroncini G; Grieco A; Nacci G; Paolini C; Tonnini C; Pozniak KN; Cuccioloni M; Mozzicafreddo M; Svegliati S; Angeletti M; Kazlauskas A; Avvedimento EV; Funaro A; Gabrielli A
Arthritis Rheumatol; 2015 Jul; 67(7):1891-903. PubMed ID: 25808833
[TBL] [Abstract][Full Text] [Related]
38. CD22 and autoimmune disease.
Dörner T; Shock A; Smith KG
Int Rev Immunol; 2012 Oct; 31(5):363-78. PubMed ID: 23083346
[TBL] [Abstract][Full Text] [Related]
39. Ablation of CD22 in ligand-deficient mice restores B cell receptor signaling.
Collins BE; Smith BA; Bengtson P; Paulson JC
Nat Immunol; 2006 Feb; 7(2):199-206. PubMed ID: 16369536
[TBL] [Abstract][Full Text] [Related]
40. Modulation of B cell regulatory molecules CD22 and CD72 in myasthenia gravis and multiple sclerosis.
Lu J; Li J; Zhu TQ; Zhang L; Wang Y; Tian FF; Yang H
Inflammation; 2013 Jun; 36(3):521-8. PubMed ID: 23184497
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
